Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $41.5000 (-5.47%) ($35.1000 - $41.5000) on Tue. Aug. 5, 2014. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.9% (three month average) | RSI | 54 | Latest Price | $41.5000(-5.47%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -0.5% a day on average for past five trading days. | Weekly Trend | CAPR advances 0.6% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) IWM(7%) JNK(7%) PEJ(7%) SPY(7%) VT(7%) | Factors Impacting CAPR price | CAPR will decline at least -2.45% in a week (0% probabilities). VIXM(-5%) TLT(-4%) UUP(-2%) GLD(-2%) SLV(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.45% (StdDev 4.9%) | Hourly BBV | 0 () | Intraday Trend | 6.4% | | | |
|
5 Day Moving Average | $40.98(1.27%) | 10 Day Moving Average | $41.58(-0.19%) | 20 Day Moving Average | $41.01(1.19%) | To recent high | -38.5% | To recent low | 7.8% | Market Cap | $817m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |